Follow
William (Wes) Salomon
William (Wes) Salomon
Tessera Therapeutics
Verified email at tesseratx.com
Title
Cited by
Cited by
Year
A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing
JD Finn, AR Smith, MC Patel, L Shaw, MR Youniss, J van Heteren, ...
Cell reports 22 (9), 2227-2235, 2018
6482018
Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties
LM Wee, CF Flores-Jasso, WE Salomon, PD Zamore
Cell 151 (5), 1055-1067, 2012
4002012
Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties
LM Wee, CF Flores-Jasso, WE Salomon, PD Zamore
Cell 151 (5), 1055-1067, 2012
4002012
Single-molecule imaging reveals that argonaute reshapes the binding properties of its nucleic acid guides
WE Salomon, SM Jolly, MJ Moore, PD Zamore, V Serebrov
Cell 162 (1), 84-95, 2015
2852015
Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing
JA Broderick, WE Salomon, SP Ryder, N Aronin, PD Zamore
Rna 17 (10), 1858-1869, 2011
1632011
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo
MR Hassler, AA Turanov, JF Alterman, RA Haraszti, AH Coles, MF Osborn, ...
Nucleic acids research 46 (5), 2185-2196, 2018
1452018
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
139*2018
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
139*2018
Modified RNAi polynucleotides and uses thereof
PA Pavco, J Kamens, TM Woolf, W Salomon, A Khvorova
US Patent 10,131,904, 2018
137*2018
Glucan particles for selective delivery of siRNA to phagocytic cells in mice
GJ Tesz, M Aouadi, M Prot, SM Nicoloro, E Boutet, SU Amano, A Goller, ...
Biochemical Journal 436 (2), 351-362, 2011
1222011
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
119*2018
Modified RNAi polynucleotides and uses thereof
PA Pavco, J Kamens, TM Woolf, W Salomon, A Khvorova
US Patent 10,131,904, 2018
1112018
Modified RNAi polynucleotides and uses thereof
PA Pavco, J Kamens, TM Woolf, W Salomon, A Khvorova
US Patent 10,131,904, 2018
1112018
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 9,080,171, 2015
952015
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
922018
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
922018
Reduced size self-delivering RNAi compounds
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, J Cardia
US Patent 10,041,073, 2018
922018
RNA interference in skin indications
A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, PA Pavco, ...
US Patent 8,664,189, 2014
702014
RNA interference in ocular indications
L Libertine, A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, ...
US Patent 9,095,504, 2015
672015
RNA interference in ocular indications
L Libertine, A Khvorova, W Salomon, J Kamens, D Samarsky, TM Woolf, ...
US Patent 9,095,504, 2015
672015
The system can't perform the operation now. Try again later.
Articles 1–20